976 results on '"Narita, Yoshitaka"'
Search Results
152. Categories for extent of resection in diffuse glioma: evidence-based recommendations
153. Safety and efficacy of TTFields for newly diagnosed GBM in Japanese patients using the Novo-TTF System: a prospective post-approval study
154. Prognostic factors of CNS germinomas; histopathological analyses on 114 cases from the iGCT consortium
155. Tissue 2-hydroxyglutarate and preoperative seizures in patients with diffuse gliomas
156. Advances in the Qualitative Diagnosis of Glioma : Correlation between Radiological Images and Genetic Alterations
157. Prognostic Factors and Histopathological Features of Pediatric Intracranial Ependymomas: Nationwide Brain Tumor Registry-based Study of Japan
158. Nationwide web questionnaire survey on clinicians’ attitudes and medical trends for cancer-associated stroke
159. O1-6-1 - Tolerability and pharmacokinetics (PK) of ABT-414 in Japanese patients (pts) with malignant glioma
160. Assessment of Therapeutic Outcome and Role of Reirradiation in Patients With Radiation-induced Glioma
161. Review of the diagnosis and treatment of brain metastases
162. COT-6 Body mass index and height in relation to brain tumor risk in a Japanese population
163. BOT-3 Prognostic Factors of CNS Germ Cell Tumors; Molecular and Histopathological Analyses on 154 Cases from the iGCT Consortium
164. RT-5 Boron Neutron Capture Therapy has extended progression-free survival about recurrent malignant peripheral nerve sheath tumor - A case report
165. STMO-17 Treatment outcome of photodynamic therapy using talaporfin sodium for recurrent high-grade glioma
166. MPC-1 DNA methylome analysis suggested the presence of “true” IDH-wildtype lower-grade gliomas
167. MPC-10 Prognostic analysis in IDH mutant astrocytoma patient with CDKN2A/B homozygous deletion
168. ACT-6 Clinical manifestations of the patients with relapsed glioblastoma after bevacizumab treatment
169. TB-4 Antitumor effects of a novel curcumin derivative curcumin monoglucuronide on glioblastoma cells in vitro and in vivo
170. Eribulin prolongs survival in an orthotopic xenograft mouse model of malignant meningioma
171. Clinical Characteristics, Treatment Outcomes, And Genetic Alterations of Radiation-Induced Gliomas
172. The Clinical Characteristics and Outcomes of Incidentally Discovered Glioblastoma
173. Quality of Life and Karnofsky Performance Status in Patients with Relapse or Refractory Primary Central Nervous System Lymphoma during Phase I/II Study of Tirabrutinib
174. RBIO-03. INITIAL RESULT OF DEVELOP ROBUST DEEP LEARNING MODEL FOR DETECTING GENOMIC STATUS IN GLIOMAS AGAINST IMAGE DIFFERENCES AMONG FACILITIES
175. Short communication: sclerosing meningioma in the deep sylvian fissure
176. Usefulness of a glass-free medical three-dimensional autostereoscopic display in neurosurgery
177. Mutually exclusive mutations of KIT and RAS are associated with KIT mRNA expression and chromosomal instability in primary intracranial pure germinomas
178. Risk factors for early death after surgery in patients with brain metastases: reevaluation of the indications for and role of surgery
179. Immunohistochemical actinin-4 expression in infiltrating gliomas: association with WHO grade and differentiation
180. A randomized phase III study of short-course radiotherapy combined with Temozolomide in elderly patients with newly diagnosed glioblastoma; Japan clinical oncology group study JCOG1910 (AgedGlio-PIII)
181. Safety and efficacy of depatuxizumab mafodotin in Japanese patients with malignant glioma: A nonrandomized, phase 1/2 trial
182. Lomustine and nimustine exert efficient antitumor effects against glioblastoma models with acquired temozolomide resistance
183. Liquid biopsy of cerebrospinal fluid for MYD88 L265P mutation is useful for diagnosis of central nervous system lymphoma
184. In Vivo Study of the Efficacy and Safety of 5-Aminolevulinic Radiodynamic Therapy for Glioblastoma Fractionated Radiotherapy
185. Determining the extent of tumor resection at surgical planning with 18F-fluciclovine PET/CT in patients with suspected glioma: multicenter phase III trials
186. Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan
187. Erratum to: Development of a robust and sensitive pyrosequencing assay for the detection of IDH1/2 mutations in gliomas
188. Health-related quality of life in long-term survivors with Grade II gliomas: the contribution of disease recurrence and Karnofsky Performance Status
189. Expression and clinical significance of genes frequently mutated in small cell lung cancers defined by whole exome/RNA sequencing
190. Revisiting TP53 Mutations and Immunohistochemistry—A Comparative Study in 157 Diffuse Gliomas
191. Secondary glioblastomas with IDH1/2 mutations have longer glioma history from preceding lower-grade gliomas
192. Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss
193. Randomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly diagnosed anaplastic astrocytoma and glioblastoma (JCOG0305)
194. Management of glioblastoma in an NF1 patient with moyamoya syndrome: a case report
195. Mathematical Modeling and Mutational Analysis Reveal Optimal Therapy to Prevent Malignant Transformation in Grade II IDH-Mutant Gliomas
196. Assessing Versatile Machine Learning Models for Glioma Radiogenomic Studies across Hospitals
197. Resection of carcinoma of the external auditory canal in a patient with a high jugular bulb using temporal craniotomy
198. Olfactory Preservation in Craniofacial Resection of Tumor Invading Hemianterior Skull Base: Operative Video
199. Efficacy finding cohort of a cancer peptide vaccine, TAS0313, in treating recurrent glioblastoma.
200. Outcomes of salvage fractionated re-irradiation combined with bevacizumab for recurrent high-grade gliomas that progressed after bevacizumab treatment**
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.